seamus dubhghaill

Promoting Irish Culture and History from Little Rock, Arkansas, USA


Leave a comment

Death of Michael Moynihan, Labour Party Politician

Michael Moynihan, Irish Labour Party politician, dies in Cork, County Cork, on June 27, 2001. He serves as Minister of State at the Department of Trade, Commerce and Tourism from 1982 to 1987. He also serves as a senator from 1973 to 1981 and as a Teachta Dála for the Kerry South constituency from 1981 to 1987 and 1989 to 1992.

Moynihan is born in Kinsale, County Cork, on June 17, 1917. He is a psychiatric nurse by profession.

Moynihan is an unsuccessful candidate in the Kerry South constituency six times, at the  1954,  1961,  1965,  1973 and  1977 Irish general elections, and at a by-election in 1966.

Moynihan is elected in 1973 to the 13th Seanad as a senator for the Industrial and Commercial Panel, which re-elects him in 1977 to the 14th Seanad.

At the 1981 Irish general election, on his seventh attempt, Moynihan is elected to the 22nd Dáil, becoming the first ever Labour Party TD for Kerry South, and returns to the 23rd Dáil at the February 1982 Irish general election. He is re-elected at the November 1982 Irish general election, sitting in the 24th Dáil. He serves as Minister of State at the Department of Trade, Commerce and Tourism from 1982 to 1987.

Moynihan is defeated at the 1987 Irish general election, but returns at the 1989 Irish general election to sit in the 26th Dáil. He does not stand at the 1992 Irish general election, when his seat is retained for the Labour Party by his daughter Breeda Moynihan-Cronin.


Leave a comment

Alexion Pharmaceuticals Announces €450m Expansion in Dublin

On May 11, 2015, Alexion Pharmaceuticals announces plans to significantly expand its operations in Ireland by constructing the company’s first ever biologics manufacturing facility outside the United States. The new 20,000 sq. metre plant will manufacture biologic drugs for treatment of rare and severe diseases.

Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts, that specializes in orphan drugs to treat rare diseases. With costs that can reach as much as $2 million per year, the drugs manufactured by Alexion are some of the most expensive drugs worldwide.

The four-year project, which will be constructed at Alexion’s College Park site in Blanchardstown, is expected to create approximately 200 additional full-time jobs on completion, which will bring Alexion’s total workforce in Ireland to almost 500 employees.

Since first entering Ireland in 2013, Alexion has invested €130m in two facilities – a vial fill and finish facility in Athlone and a global supply chain facility at College Park. Phase one of the College Park facility, comprising Global Supply Chain HQ, laboratories, packaging and warehousing operations is expected to be operational by year end. Approximately 560 construction workers are involved in the development of the current Athlone and College Park projects, and the planned expansion of College Park will also create over 800 construction jobs.

Alexion has worked closely with the Department of Jobs and IDA Ireland on the development of its operations in Ireland.

Julie O’Neill, EVP Global Operations, states, “Alexion is pleased to progress the development of our College Park facility with a significant expansion that will now include our first biologics manufacturing facility outside the United States. This project further underscores our commitment to Ireland and is enabled by our ability to recruit highly competent and professional personnel to support the production and distribution of our medicine, Soliris (Eculizumab), and our strong pipeline of biologics medicines. Alexion has a unique mission to develop life-transforming therapies for patients with severe and life-threatening ultra-rare disorders. We are already serving the very few patients in Ireland suffering from two very rare and devastating diseases; with this major expansion, our Irish operations, comprising biologics manufacturing, vial fill-finish and global supply chain, will be at the forefront of this vital work globally.”

Welcoming the announcement, Tánaiste and Minister for Social Protection Joan Burton TD says, “Alexion’s latest expansion is an extremely strong endorsement for Ireland, and Dublin West in particular, as an attractive location for high-end investment from the pharmaceutical industry. It underlines the jobs-led recovery that is underway, with 90,000 jobs created and the Live Register down by a third since the peak of the crisis. We are determined to maintain this progress into the future. As Tánaiste and Social Protection Minister, my Department stands ready to assist Alexion with their recruitment needs, in particular through our Employer Engagement Unit.”

Speaking at College Park, the Minister for Jobs, Enterprise and Innovation Richard Bruton TD adds, “Biopharma is a sector which we have specifically targeted as part of the Action Plan for Jobs, due to the large potential for employment growth which it offers Ireland, and we have taken a number of steps to support the growth of this sector in Ireland. Today’s announcement by Alexion is a huge boost for west Dublin and the whole country, and huge credit is owed to Julie and her team as well as the IDA. Employment will be provided for 1,000 extra people, and the knock-on impact of this massive €450m investment for the wider economy will be enormous. We are developing a powerful cluster of biopharma plants in Ireland which I am determined now to build on.”